Test Price
2,800 AED✅ Home Collection Available
SFTPA1 Gene Idiopathic Pulmonary Fibrosis Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Diagnostic Precision & Service Excellence
- Accuracy Assurance: 99.9% diagnostic sensitivity achieved through ISO 9001:2015 certified NGS methodology.
- Premium Logistics: VIP mobile phlebotomy with temperature‑controlled cold‑chain, available daily 8 AM–11 PM.
- Clinical Guidance: Post‑test telephone consultation with a Consultant Medical Geneticist to interpret results.
- Insurance Support: Direct coverage verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This test employs Next‑Generation Sequencing (NGS) to comprehensively analyze the SFTPA1 gene, detecting pathogenic variants associated with idiopathic pulmonary fibrosis (IPF) and familial interstitial pneumonia. It enables early diagnosis, family risk stratification, and personalised management of pulmonary fibrosis.
| Feature | Our SFTPA1 NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Method | Next‑Generation Sequencing (NGS) | Sanger Sequencing |
| Gene Coverage | Full gene ± regulatory regions; detects SNVs, indels, CNVs | Limited to selected exons only |
| Diagnostic Sensitivity | 99.9% | 80–85% (depending on target region) |
| Turnaround Time | 3–4 Weeks | 2–3 Weeks |
| Price | 2800 AED | ~2200 AED |
Physician Insight & Safety Protocols
“Genetic testing for idiopathic pulmonary fibrosis must always be interpreted within the full clinical context. A negative result does not exclude the disease, while a positive finding should prompt genetic counselling and possible screening of at‑risk relatives. This test is a powerful tool for precision medicine when guided by a multidisciplinary team.”
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
⚠️ Medication Safety Advisory
Do not discontinue or alter any prescribed medication, including antifibrotics or immunosuppressants, without consulting your treating physician. Test results are not a substitute for professional medical advice.
Patient Safety Exclusion & Emergency Red Flags
- Exclusion Criteria: Active febrile illness requiring hospitalisation, inability to provide informed consent, or recent blood transfusion (<2 weeks) may affect sample suitability.
- ER Red Flags – Seek Immediate Medical Attention if you experience: Sudden worsening shortness of breath, chest pain, bluish lips or fingertips (cyanosis), or fainting.
Patient FAQ & Clinical Guidance
1. What is the SFTPA1 gene test used for?
This NGS test analyses the SFTPA1 gene to identify pathogenic variants associated with idiopathic pulmonary fibrosis, enabling early diagnosis and family risk assessment. Mutations in SFTPA1 are linked to both sporadic and familial forms of pulmonary fibrosis, helping clinicians tailor surveillance and treatment plans for affected individuals and at‑risk relatives.
2. How is the test performed and what preparation is required?
A healthcare professional collects a small blood sample (or extracted DNA) during a painless venipuncture, with mandatory pre‑test genetic counselling. You must attend a genetic counselling session to document your family history (pedigree chart) before sample collection. Fasting is not required, but please inform the lab of any recent medications or transfusions. Our VIP mobile phlebotomy service brings the ISO‑certified cold‑chain collection to your home.
3. How long do results take and what do they mean?
Results are typically available within 3 to 4 weeks and include a comprehensive report of any detected pathogenic or likely pathogenic variants. A genetic counsellor or your referring physician will interpret the findings, explaining the implications for your health and any necessary follow‑up. A negative result does not rule out idiopathic pulmonary fibrosis, as other genes or environmental factors may be involved.
UAE Regulatory & Data Privacy Adherence
Data Protection & Clinical Compliance
This test complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures follow Federal Decree‑Law No. 4 of 2016 on Medical Liability, ensuring patient consent and safety standards are strictly observed.
Testing is performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | SFTPA1 Gene Idiopathic Pulmonary Fibrosis Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube) – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM–11 PM |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full gene ± regulatory regions |
| ICD-10-CM Code | J84.112 (Idiopathic pulmonary fibrosis) |
| LOINC Code | 81303-0 (Genetic analysis of gene region) |
| DHA Facility License & Laboratory Address | License No: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians